Hims & Hers’ expansion plans — as well as its Super Bowl ad — have investors worried about profits
The wellness platform’s results arrived amid heightened legal and regulatory scrutiny over its weight-loss-drug business.
Last updated: 2026-02-24 02:53:54 ET
The wellness platform’s results arrived amid heightened legal and regulatory scrutiny over its weight-loss-drug business.
Elliptic says that despite increased regulatory pressure, a handful of crypto exchanges continue to serve sanctioned Russian entities.
Recruitment of children for study delayed after MHRA warns that participants should be no younger than 14 A clinical trial into puberty blockers for c...
Bitcoin is entering a structurally different phase of its market life. After more than a decade defined by extreme volatility, regulatory uncertainty,...
Medical robotics is not just a futuristic idea today. That’s why you now witness many robotic systems assisting surgeons, helping with rehab therapy...
For the last few years, if you’ve followed trucking headlines, you’d think the entire industry is falling apart. Fraud schemes. Cargo theft. Crash...
In February 2026, Moderna reported full-year 2025 revenue of US$1.94 billion and a net loss of US$2.82 billion, while the FDA’s vaccines ...
The Horseracing Integrity and Safety Authority filed a complaint saying Churchill Downs Inc. is not paying its fair share to support inspections and t...
Pfizer (NYSE:PFE) reported positive topline results from its pivotal BREAKWATER trial. The study evaluated a BRAFTOVI based combination in previously ...